Adult body mass index and risk of ovarian cancer by subtype: A Mendelian randomization study

International Journal of Epidemiology

Volumn 45, Issue 3, 2016, Pages 884-895

  Dixon, Suzanne C ^a,b   Nagle, Christina M ^a,b   Thrift, Aaron P ^c   Pharoah, Paul D P ^d   Pearce, Celeste Leigh ^e,f   Zheng, Wei ^g   Painter, Jodie N ^a   Chenevix Trench, Georgia ^a   Fasching, Peter A ^h,i   Beckmann, Matthias W ⁱ   Lambrechts, Diether ^j,k   Vergote, Ignace ^l   Lambrechts, Sandrina ^l   Van Nieuwenhuysen, Els ^l   Rossing, Mary Anne ^m,n   Doherty, Jennifer A ^o   GWicklund, Kristine ^m   Chang Claude, Jenny ^p   Rudolph, Anja ^p   Moysich, Kirsten B ^q   Odunsi, Kunle ^q   Goodman, Marc T ^r   Wilkens, Lynne R ^s   Thompson, Pamela J ^r   Shvetsov, Yurii B ^s   Dörk, Thilo ^t   Park Simon, Tjoung Won ^t   Hillemanns, Peter ^t   Bogdanova, Natalia ^t   Butzow, Ralf ^u   Nevanlinna, Heli ^u   Pelttari, Liisa M ^u   Leminen, Arto ^u   Modugno, Francesmary ^v,w,x   Ness, Roberta B ^y   Edwards, Robert P ^v,w   Kelley, Joseph L ^v   Heitz, Florian ^z,aa   Karlan, Beth Y ^r   Kjær, Susanne K ^ab,ac   Høgdall, Estrid ^ab,ac   Jensen, Allan ^ab   Goode, Ellen L ^ad   Fridley, Brooke L ^ae   Cunningham, Julie M ^ad   Winham, Stacey J ^ad   Giles, Graham G ^af,ag,ah   Bruinsma, Fiona ^af   Milne, Roger L ^af,ag   Southey, Melissa C ^ai   Hildebrandt, Michelle A T ^aj   Wu, Xifeng ^aj   Lu, Karen H ^aj   Liang, Dong ^ak   Levine, Douglas A ^al   Bisogna, Maria ^al   Schildkraut, Joellen M ^am,an   Berchuck, Andrew ^am   Cramer, DanielW ^ao   Terry, Kathryn L ^ao   Bandera, Elisa V ^ap   Olson, Sara H ^al   Salvesen, Helga B ^aq,ar   Thomsen, Liv Cecilie ^aq,ar   Kopperud, Reidun K ^aq,ar   Bjorge, Line ^aq,ar   Kiemeney, Lambertus A ^as   Massuger, Leon F A G ^at   Pejovic, Tanja ^au,av   Cook, Linda S ^aw   Le, Nhu D ^ax   Swenerton, Kenneth D ^ay   Brooks Wilson, Angela ^ax,az   Kelemen, Linda E ^ba   Lubiński, Jan ^bb   Huzarski, Tomasz ^bb   Gronwald, Jacek ^bb   Menkiszak, Janusz ^bb   Wentzensen, Nicolas ^bc   Brinton, Louise ^bc   Yang, Hannah ^bc   Lissowska, Jolanta ^bd   Høgdall, Claus K ^ac   Lundvall, Lene ^ac   Song, Honglin ^be   Tyrer, Jonathan P ^be   Campbell, Ian ^ai,bf   Eccles, Diana ^bg   Paul, James ^bh   Glasspool, Rosalind ^bh   Siddiqui, Nadeem ^bi   Whittemore, Alice S ^bj   Sieh, Weiva ^bj   McGuire, Valerie ^bj   Rothstein, Joseph H ^bj   Narod, Steven A ^bk   Phelan, Catherine ^bl   Risch, Harvey A ^bm   McLaughlin, John R ^bn   Anton Culver, Hoda ^bo,bp   Ziogas, Argyrios ^bo   Menon, Usha ^bq   Gayther, Simon A ^f   Ramus, Susan J ^f   Gentry Maharaj, Aleksandra ^bq   Wu, Anna H ^f   Pike, Malcolm C ^al   Tseng, Chiu Chen ^f   Kupryjanczyk, Jolanta ^bd   Dansonka Mieszkowska, Agnieszka ^bd   Budzilowska, Agnieszka ^bd   Spiewankiewicz, Beata ^bd   Webb, Penelope M ^a,b   more..

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^j DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^k UNIVERSITY OF LEUVEN   (Belgium)

^l UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^m USA   (United States)

ⁿ UNIVERSITY OF WASHINGTON   (United States)

^o DARTMOUTH MEDICAL SCHOOL   (United States)

^p GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^q ROSWELL PARK CANCER INSTITUTE   (United States)

^r CEDARS SINAI MEDICAL CENTER   (United States)

^s UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^t HANNOVER MEDICAL SCHOOL   (Germany)

^u HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^v UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^w UNIVERSITY OF PITTSBURGH   (United States)

^x UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^y UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^z KLINIKEN ESSEN MITTE   (Germany)

^aa DR HORST SCHMIDT KLINIKEN   (Germany)

^ab DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^ac UNIVERSITY OF COPENHAGEN   (Denmark)

^ad MAYO CLINIC   (United States)

^ae UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^af CANCER EPIDEMIOLOGY CENTRE   (Australia)

^ag UNIVERSITY OF MELBOURNE   (Australia)

^ah MONASH UNIVERSITY   (Australia)

^ai UNIVERSITY OF MELBOURNE   (Australia)

^aj UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^ak TEXAS SOUTHERN UNIVERSITY   (United States)

^al MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^am DUKE UNIVERSITY MEDICAL CENTER   (United States)

^an DUKE CANCER INSTITUTE   (United States)

^ao BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ap RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^aq HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^ar UNIVERSITY OF BERGEN   (Norway)

^as RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^at RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^au OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^av OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^aw UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^ax BRITISH COLUMBIA CANCER AGENCY   (Canada)

^ay UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^az SIMON FRASER UNIVERSITY   (Canada)

^ba MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^bb POMERANIAN MEDICAL UNIVERSITY   (Poland)

^bc NATIONAL CANCER INSTITUTE   (United States)

^bd INSTITUTE OF ONCOLOGY   (Poland)

^be UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^bf PETER MACCALLUM CANCER CENTRE   (Australia)

^bg UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^bh BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^bi GLASGOW ROYAL INFIRMARY   (United Kingdom)

^bj STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bk UNIVERSITY OF TORONTO   (Canada)

^bl H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^bm YALE UNIVERSITY   (United States)

^bn PUBLIC HEALTH ONTARIO   (Canada)

^bo UNIVERSITY OF CALIFORNIA   (United States)

^bp UNIVERSITY OF CALIFORNIA   (United States)

^bq UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Body mass index; Mendelian randomization analysis; Obesity; Ovarian neoplasms

Indexed keywords

ALLELE; BODY MASS; CANCER; GENETIC MARKER; HEALTH RISK; INDEX METHOD; OBESITY;

ALLELE; ARTICLE; BODY MASS; CANCER LOCALIZATION; CANCER RISK; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENDELIAN RANDOMIZATION ANALYSIS; OUTCOME ASSESSMENT; OVARY CANCER; PARITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR INVASION; ADOLESCENT; ADULT; AGED; COMPLICATION; GENETIC MARKER; GENETICS; META ANALYSIS (TOPIC); MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; OVARY TUMOR; RISK FACTOR; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; BODY MASS INDEX; FEMALE; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LOGISTIC MODELS; MENDELIAN RANDOMIZATION ANALYSIS; META-ANALYSIS AS TOPIC; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 85002548288     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyw158     Document Type: Article

References (29)

1. Olsen CM, Nagle CM, Whiteman DC et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer 2013;20:251-62
2. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: individual participant meta-analysis including 25, 157 women with ovarian cancer from 47 epidemiological studies. PLoS Med 2012;9:e1001200
3. Howlader N, Noone AM, Krapcho M et al. SEER Cancer Statistics Review, 1975-2012. Bethesda, MD: National Cancer Institute, 2015
4. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22
5. Salvador S, Gilks B, Kobel M, Huntsman D, Rosen B, Miller D. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer 2009;19:58-64
6. Gayther SA, Song H, Ramus SJ et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2007;67:3027-35
7. Pharoah PDP, Tsai YY, Ramus SJ et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013;45:362-70
8. Abecasis GR, Altshuler D, Auton A et al. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-73
9. Locke AE, Kahali B, Berndt SI et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015;518:197-206
10. Burgess S. Identifying the odds ratio estimated by a two-stage instrumental variable analysis with a logistic regression model. Stat Med 2013;32:4726-47
11. Didelez V, Meng S, Sheehan NA. Assumptions of IV methods for observational epidemiology. Stat Sci 2010;25:22-40
12. Palmer TM, Sterne JA, Harbord RM et al. Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses. Am J Epidemiol 2011;173:1392-403
13. Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 2013;178:1177-84
14. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013;37:658-65
15. Stukel TA, Demidenko E, Dykes J, Karagas MR. Two-stage methods for the analysis of pooled data. Stat Med 2001;20:2115-30
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88
17. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58
18. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015;44:512-25
19. Nagle CM, Olsen CM, Webb PM, Jordan SJ, Whiteman DC, Green AC. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer 2008;44:2477-84
20. Risch H, Marrett L, Jain M, Howe G. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a casecontrol study. Am J Epidemiol 1996;144:363-72
21. Goodman MT, Shvetsov YB. Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact? Int J Cancer 2009;124:2231-35
22. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 2014;384:755-65
23. Louie SM, Roberts LS, Nomura DK. Mechanisms linking obesity and cancer. Biochim Biophys Acta 2013;1831:1499-508
24. Olsen CM, Green AC, NagleCMet al. Epithelial ovarian cancer: testing the 'androgens hypothesis'. Endocr Relat Cancer 2008;15:1061-68
25. Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 2007;16:309-30
26. Staiger DO. Instrumental variables regression with weak instruments. Econometrica 1997;65:557-86
27. Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014;23:R89-R98
28. International Agency for Research on Cancer. GLOBOCAN 2012. 2014. http://globocan.iarc.fr/(23 December 2015, date last accessed)
29. Ng M, Fleming T, Robinson M et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-81